About
Keith Crandell is a co-founder and Managing Director of ARCH Venture Partners, a major deep-tech and life sciences venture firm. He focuses on therapeutics, tools, diagnostics, instrumentation, photonics, and specialty materials, and has been involved in the formation or funding of companies including Twist Bioscience, 908 Devices, Arbor Biotechnologies, Cytrellis, Quanterix, Scale Biosciences, and Vizgen. Beyond investing, he holds numerous board and advisory roles across biotech and university innovation ecosystems.
Areas of interest
life sciencesbiotechtherapeuticsdiagnosticsmedical devicesgenomicsgene editingsynthetic biologysingle-molecule imaginganalytical instrumentschemical and specialty materialselectronicsdeep techaging/longevityuniversity spinouts